Daptomycin Therapy for Osteomyelitis: A Retrospective Study
<p>Abstract</p> <p>Background</p> <p>Daptomycin is a rapidly bactericidal agent with broad coverage against Gram-positive organisms, including <it>Staphylococcus aureus,</it> the most frequent cause of osteomyelitis. The objective of this study was to descri...
Main Authors: | Gallagher Jason C, Huntington Jennifer A, Culshaw Darren, McConnell Scott A, Yoon Minjung, Berbari Elie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-06-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/12/133 |
Similar Items
-
Oritavancin Versus Daptomycin for Osteomyelitis Treatment After Surgical Debridement
by: Nicholas W. Van Hise, et al.
Published: (2024-02-01) -
Daptomycin in the Treatment of Diabetic Foot Infections without Osteomyelitis; A Multicenter Study
by: Meltem IŞIKGÖZ TAŞBAKAN, et al.
Published: (2017-12-01) -
Daptomycin Experience in Patients with Human Immunodeficiency Virus and Resistant Gram-Positive Infections
by: Jihad Slim MD, et al.
Published: (2015-05-01) -
Hyperbaric Oxygen Therapy is Ineffective as an Adjuvant to Daptomycin with Rifampicin Treatment in a Murine Model of Staphylococcus aureus in Implant-Associated Osteomyelitis
by: Nis Pedersen Jørgensen, et al.
Published: (2017-04-01) -
Efficacy of Daptomycin-Containing Regimen for Treatment of Staphylococcal or Enterococcal Vertebral Osteomyelitis: A Prospective Clinical Experience
by: Alessandro Russo, et al.
Published: (2020-12-01)